Serum prolactin and CA 125 levels in uterine adenomyosis
article
OA: closed
CC0
⤵ 1 in-corpus citation
AI-generated summary
This study found no significant difference in serum prolactin and cancer antigen 125 levels between adenomyosis patients with smaller versus larger uterine volumes.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
Abstract
Objective: It is suggested that prolactin has a role in the pathogenesis of uterine adenomyosis. Besides, it is also reported that elevated cancer antigen 125 levels are related with this benign disorder. The aim of the study was to investigate serum prolactin and cancer antigen 125 levels in patients with adenomyosis. Methods: In this retrospective chart review study, data of patients with clinically diagnosed and histopathologically proven adenomyosis in hysterectomy specimens were analyzed. Patients were divided into two groups according to the ultrasonographically calculated preoperative uterine volume: Group 1 (n = 62): uterine volume ⩽240 cm 3 (⩽12 gestational weeks) and Group 2 (n = 42): uterine volume >240 cm 3 (>12 gestational weeks). Age, obstetric history, body mass index, preoperative hemoglobin, thyroid stimulating hormone, prolactin and cancer antigen 125 levels, and ultrasonographic findings were recorded. Preoperative prolactin and cancer antigen 125 values were compared between the two groups. Results: A total of 104 patients were included in the study. No differences in the baseline characteristics were observed between the groups, except the number of pregnancies and miscarriages. Furthermore, no significant differences were observed in terms of serum prolactin and cancer antigen 125 levels between the groups. Conclusion: Serum prolactin and cancer antigen 125 levels were not associated with uterine volume in patients with uterine adenomyosis.
My notes (saved in your browser only)
Condition tags
Citation neighborhood
Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.
References (21)
- Adenomyosis: via openalex
- Adenomyosis does not affect implantation, but is associated with miscarriage in patients undergoing oocyte donation via openalex
- Adenomyosis reduces pregnancy rates in infertile women undergoing IVF via openalex
- Adenomyosis: the pathophysiology of an oestrogen-dependent disease via openalex
- Effects of prenatal exposure of mice to “low-dose” diethylstilbestrol and the development of adenomyosis associated with evidence of hyperprolactinemia via openalex
- Increased expression of prolactin receptor mRNA in adenomyotic uterus in mice via openalex
- Mechanisms of Development of Prolactin-Induced Adenomyosis in Mice via openalex
- Neutrophil to Lymphocyte Ratio and Platelet to Lymphocyte Ratio Can be Useful Markers for Distinguishing Uterine Adenomyosis and Leiomyoma via openalex
- Prolactin role in the bovine uterus during adenomyosis via openalex
- Severe adenomyosis and CA125 via openalex
- The elusive adenomyosis of the uterus via openalex
- The rate of euploid miscarriage is increased in the setting of adenomyosis via openalex
- Ultrasound-guided percutaneous microwave ablation for adenomyosis: efficacy of treatment and effect on ovarian function via openalex
- Usefulness of CA125 in the differential diagnosis of uterine adenomyosis and myoma via openalex
- Uterine adenomyosis and in vitro fertilization outcome: a systematic review and meta-analysis via openalex
- Vaginal bromocriptine improves pain, menstrual bleeding and quality of life in women with adenomyosis: A pilot study via openalex
- W2482591334 via openalex
- W2515052691 via openalex
- W2027283107 via openalex
- W2016594241 via openalex
- W1965039757 via openalex
Cited by (1)
Source provenance
- openalex
- last seen: 2026-06-04T00:00:01.174412+00:00
License: CC0
· commercial use OK